Janus Henderson Investors launches horizon biotechnology fund

Janus Henderson Investors launches horizon biotechnology fund

Janus Henderson Investors has launched Horizon Biotechnology fund. This Luxembourg domiciled SICAV will invest in innovative biotechnology and biotechnology-related companies that seek to address high unmet medical needs around the world. The fund will target long-term growth within this fast growing and innovative sector. It will be co-managed by Andy Acker and Dan Lyons, who have more than 40 years of combined experience investing in biotechnology. Ignacio de la Maza, head of Continental...

To continue reading this article...

Join International Investment

Join International Investment today

Unlock members-only benefits:

  • Unlimited access to real-time news, industry insights, video features and market intelligence
  • Stay ahead of the curve with spotlights on international financial centres, regional trends international advice and global industry leaders
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Hear the latest cross jurisdictional developments in wealth planning, tax, regulation, investing, retirement and protection
  • Members-only access to the Editor’s weekly news roundup newsletter
  • Members-only access to analysis via our exclusive industry polls
  • Be the first to hear about our events and awards programmes

Join now


Already a International Investment member?